China’s first mRNA vaccine is close — will that solve its COVID woes?

Ye, Yvaine

doi:10.1038/d41586-022-01690-3

Cited by 4 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With China's new 20 guidelines for easing the "Zero COVID" policy, the world's manufacturing hub will gradually lift COVID-19 restrictions, which will stimulate the vitality of the global supply network and economy. Given the successful rollout of vaccination programs 41 , our results provide timely data-driven evidence that supports the reopening in China.…”

Section: Discussionmentioning

confidence: 68%

Supply chain loss from easing COVID-19 restrictions: an evolutionary epidemiological-economic modeling study

Zhang

Yang

Cao

et al. 2023

Preprint

View full text Add to dashboard Cite

Since the start of the COVID-19 pandemic, many firms have been shifting their supply chains away from countries with stringent control measures to mitigate supply chain disruption. Nowadays, the global economy is reopening from the COVID-19 pandemic at various paces in different countries. Understanding how the global supply network evolves during and after the pandemic is necessary for determining the timing of reopening. By harnessing the real-world and real-time global human movement and the latest macroeconomic data, we propose an evolutionary epidemiological-economic model to explore the evolutionary dynamics of the global supply network under various global reopening scenarios. We find that the delay in full reopening in highly restrictive countries has limited public health benefits in the long run but leads to significant supply chain loss to less restrictive ones. Longer duration of stringent control measures leads to lower supply chain recovery in five years. The recovery rate varies across production sectors, depending on the characteristics of production, the degree of self-reliance, and the location of production hubs. This research presents the first data-driven evidence of supply chain loss due to the timing of reopening and sheds light on the post-pandemic supply chain reformation and recovery. Our results provide data-driven evidence that supports the reopening in countries with high vaccine coverage.

show abstract

Section: Discussionmentioning

confidence: 68%

Supply chain loss from easing COVID-19 restrictions: an evolutionary epidemiological-economic modeling study

Zhang

Yang

Cao

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Under the guidance of the Central Leading Group, the Ministry of Industry and Information Technology ordered factories to step up the production of critical medical equipment such as masks, testing kits, protective suits, and infrared body thermometers, guaranteeing to purchase and stockpile overcapacities (Duchatel et al 2020 , p. 48). Similar measures were taken to develop domestic vaccines: already by late 2020, China approved its first own inactivated anti-COVID-19 vaccine, being followed by six more domestic vaccines by late 2021 (Ye 2022 ). This allowed the PRC to inoculate hospital and other critical infrastructure personnel early on, but also to donate its vaccines to developing countries within the COVAX scheme—an international effort to deliver vaccines to poorer countries on an equitable basis, after approval by the WHO.…”

Section: Locked In Seclusion: Ideological Fixation On Zero-covid In T...mentioning

confidence: 99%

“…Since then, similar patterns have been observed in various other metropolises across China, where citizens have taken to both online and offline forms of protest to vent their anger about extended confinement, a lack of food and daily necessities, and even losses of life due to neglect, accidents during forced quarantine, or from other unrelated diseases in a health system preoccupied with Zero-COVID. 2 In the meantime, news has emerged that Chinese state-owned enterprises are experimenting with domestic mRNA vaccines—but there still seems a long way to go before they can be rolled out and bring down hospitalization rates (Ye 2022 ).…”

Section: Locked In Seclusion: Ideological Fixation On Zero-covid In T...mentioning

confidence: 99%

Navigating the dual dilemma between lives, rights and livelihoods: COVID-19 responses in China, Singapore, and South Korea

Holbig

2023

Z Vgl Polit Wiss

View full text Add to dashboard Cite

The COVID-19 pandemic has created a dual dilemma for governments worldwide: between the protection of lives and of individual rights, and more long-term between safeguarding lives and preserving livelihoods. Taking a dynamic approach, this paper asks how different regime types have navigated this dual dilemma by adjusting their pandemic-response strategies over the course of time. Three case studies from East Asia are selected to represent different regime types—autocratic China, hybrid Singapore, and democratic South Korea—that share experience with previous coronavirus episodes. Comparing the three cases between late 2019 to mid-2022, remarkable differences are found in the adaptability of response strategies. China’s authoritarian regime appeared to be at a clear strategic advantage due to its indifference toward individual rights during the first COVID-19 wave. In the longer run, however, the picture has changed substantially. While China has exclusively prioritized the protection of lives, fixating on its “Zero-COVID” strategy, Singapore has attached at least equal weight to sustaining livelihoods, experiencing a drawn-out zigzagging before pivoting to a “Living with COVID” strategy. Among the three cases, only South Korea has made consistent efforts to protecting individual rights while gradually recalibrating lives and livelihoods. Over time, the high degree of responsiveness of South Korea’s democratic regime has allowed for a relatively smooth transition to coexisting with the virus. The paper concludes with some lessons that European democracies might learn from pandemic responses in East Asia in a longitudinal perspective.

show abstract

Information-Seeking Behavior for COVID-19 Boosters in China: A Cross-Sectional Survey

Hubbard

et al. 2023

Vaccines

View full text Add to dashboard Cite

As China launches its second COVID-19 booster campaign and races to bring new vaccine technologies to protect against severe COVID-19 infections, there is limited research on how Chinese residents search for vaccine-related information. This study examined the factors influencing Chinese residents’ information-seeking behaviors regarding COVID-19 boosters with a sample of 616 respondents with a mean age of 31.53 from a research panel. Structural equation modeling was used to report factors that influenced respondents’ seeking intent. The results indicated that seeking-related subjective norms (β = −0.55, p < 0.001), negative affect (β = 0.08, p < 0.05), positive affect (β = 0.18, p< 0.001), and perceived knowledge insufficiency (β =0.10, p < 0.001) are strong predictors of one’s seeking intent. We also discovered that there was an inverse relationship between risk perception and positive affect (β = −0.55, p < 0.001) and between negative and positive affect (β = −0.19, p < 0.01), while all measurements were either directly or indirectly related to information-seeking intent. A few more indirect but important relationships were also included in our discussion. In conclusion, the present study helps understand what motivates Chinese residents to seek COVID-19 booster information when limited information is available.

show abstract

China’s first mRNA vaccine is close — will that solve its COVID woes?

Cited by 4 publications

References 6 publications

Supply chain loss from easing COVID-19 restrictions: an evolutionary epidemiological-economic modeling study

Supply chain loss from easing COVID-19 restrictions: an evolutionary epidemiological-economic modeling study

Navigating the dual dilemma between lives, rights and livelihoods: COVID-19 responses in China, Singapore, and South Korea

Information-Seeking Behavior for COVID-19 Boosters in China: A Cross-Sectional Survey

Contact Info

Product

Resources

About